Cardiogen

Cardiogen

Cardiogen is a research-grade tetrapeptide of Russian bioregulator origin, developed for preclinical investigation of cardiac tissue biology and myocardial gene expression. As part of the Khavinson peptide bioregulator series, Cardiogen is a short-chain peptide studied for its interactions with cardiac cell DNA and its effects on gene expression associated with cardiomyocyte biology. It is supplied as a lyophilised extract for use in in vitro and in vivo research models.

Mechanism of Action

Cardiogen is hypothesised to act as a gene expression modulator, interacting with chromatin and influencing the transcription of genes involved in cardiac cell differentiation and protein synthesis. Peptide bioregulators of this class are thought to exhibit tissue-specific activity by binding to complementary DNA sequences in target cells. Research has focused on its effects on cardiomyocyte viability and gene expression in experimental models.

Research Applications

• Cardiomyocyte biology and cardiac tissue gene expression studies
• Peptide bioregulator chromatin interaction research
• Myocardial function preclinical modelling
• Ageing and cellular senescence investigation in cardiac tissue
• Tissue-specific peptide bioregulator activity studies

Specifications

• Molecular Formula: C₁₈H₃₁N₇O₉
• CAS Number: N/A
• Purity: ≥98%
• Molecular Weight: 489.48 g/mol
• Form: Lyophilised extract
• Storage: -20°C
• Shelf Life: 24 months

This product is intended for legitimate laboratory and analytical research use only. Not for human use, veterinary use, or consumer use. Not for diagnostic or therapeutic purposes.